Skip to main content

Table 1 Demographics and outcome of the patients

From: A single oral dose of Silodosin and Diclofenac sodium is effective in reducing pain after ureteric stent removal: a prospective, randomized, double blind placebo-controlled study

Variables Placebo Diclofenac Silodosin Silodosin + Diclofenac p value
Group A Group B Group C Group D
Mean ± SD age in years 34.7 ± 10.8 36.4 ± 13.5 32.3 ± 9.9 40.2 ± 9.8 0.17
Sex M/F 40/13 45/11 36/15 42/16 0.38
Diagnosis
 Ureteric stone 47 51 48 49 0.26
 Renal stone 6 5 3 9  
Side
 Left 28 18 21 31 0.90
 Right 25 38 30 27  
Mean ± SD duration of stenting in days 23.5 ± 3.7 25.4 ± 2.6 21.7 ± 2.3 22.5 ± 2.8 0.06
A–C (0.01)
Mean ± SD pre-stent removal VAS score 3.4 ± 0.9 3.5 ± 0.9 3.7 ± 1.0 3.2 ± 0.8 0.98
Mean ± SD post stent removal VAS score 4.2 ± 1.3 2.9 ± 1.1 3.1 ± 1.2 2.8 ± 1.0 <0.001
B–A (<0.001)
C–A (<0.001)
D–A (<0.001)
Post stent removal VAS score
 ≤5 44 53 46 57 0.35
 >5 9 3 5 2  
Mean ± SD additional analgesics requirement in mg (i.v morphine equivalents) 9 ± 0.7 4 ± 0.9 6 ± 0.8 3 ± 1.1 0.07